News & Trends

• 052024-08

  The innovative anti-tumor drug JK06 was approved for overseas clinical trial

• 012024-08

  Enarodustat’s new indication approved for clinical trial

• 312024-07

  SAL0120 tablets for treatment of chronic kidney disease(CKD) approved for clinical trial

• 052024-07

  Innovative type 2 diabetes drug Fultagliptin benzoate tablet (Xinliting) obtained marketing authorization

• 212024-05

  The new anti-hypertension drug “Allisartan and Amlodipine tablets” (FoLitan®) approved for market

• 072024-04

  JK07 for the treatment of chronic heart failure in adults was approved for Phase II clinical trial in China Abstract: A Phase II clinical trial in adults with chronic heart failure (RENEU-HF) was initiated